UNIVERSITY OF ILLINOIS - AWARD OF TASK ORDER 3 ENTITLED "A DUAL AKT/PDPK1 INHIBITOR FOR ACTINIC KERATOSIS AND SKIN CANCER PREVENTION IN IMMUNOCOMPROMISED INDIVIDUALS"
Key Details
Description
AWARD OF TASK ORDER 3 ENTITLED "A DUAL AKT/PDPK1 INHIBITOR FOR ACTINIC KERATOSIS AND SKIN CANCER PREVENTION IN IMMUNOCOMPROMISED INDIVIDUALS"
Context & Analysis
On Dec 16, 2025, Department of Health and Human Services obligated $2,273,213.36 to UNIVERSITY OF ILLINOIS for award of task order 3 entitled "a dual akt/pdpk1 inhibitor for actinic keratosis and skin cancer prevention in immunocompromised individuals". The award is classified under NAICS 541711 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY and issued as a firm fixed price contract. Competition extent: full and open competition with 2 offers received. Performance is located in URBANA, IL. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541711 — related awards are listed below.
Contractor Information
Similar Awards
CERUS - DEVELOPMENT AND IMPLEMENTATION OF PATHOGEN REDUCTION TECHNOLOGY (PRT). IGF::OT::IGF
CERUS CORPORATION
$185.5M
THE MEDICINE COMPANY - ADVANCE THE DEVELOPMENT OF A PORTFOLIO OF ANTI-INFECTIVE PROGRAMS. IGF::OT::IGF
MEDICINES COMPANY, THE
$98.1M
IGF::OT::IGF
JANSSEN VACCINES & PREVENTION B.V.
$48.9M
IGF::OT::IGF - DNAE / PATHOGEN IDENTIFICATION FROM SPECIMEN, VIA CAPTURE, EXTRACTION AND SEQUENCING (PISCES)
DNAE GROUP HOLDINGS LIMITED
$43.4M
AUTOGRAFT-SPARING PRODUCTS FOR DEFINITIVE CARE OF BURN INJURIES
AVITA MEDICAL AMERICAS, LLC
$40.8M
Stay Updated
Get notified about new opportunities matching your interests.